13F filer · CIK 318989 ↗

FIL Ltd

You are looking at Q3 2017. See the latest, Q2 2026 →

Reported value

$34.88B

+0.6% on the quarter before

Positions

500

45 new · 56 sold out

Top 10

24.1%

of the value

Est. gain

+$1.58B

on stocks held all quarter

Est. return

+5.2%

on those stocks since Q2 2017

Filed

Nov 13, 2017

On SEC EDGAR ↗

Positions as of Sep 30, 2017, from FIL Ltd's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

The 24 largest positions, 39% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2017. Striped tiles are options.

Alibaba6.4%Oracle2.8%
Citigroup Inc2.7%
Alphabet2.3%
Abbott Labs1.8%
Johnson & Johnson1.8%
Berkshire Hathaway Inc Del1.7%
Willis Towers Watson Pub Ltd1.7%
Pfizer Inc1.6%
Baidu1.5%
Molson Coors Brewing Co1.3%
Apple1.3%Cisco1.2%
Verizon Communications Inc1.2%
Cigna Corporation1.2%
Microsoft1.1%
Jpmorgan Chase & Co1.1%
General Electric Co1.0%
L3 Technologies Inc1.0%
Us Bancorp Del1.0%
Ctrip Com Intl Ltd0.9%
Bank New York Mellon Corp0.9%
Dell Technologies Inc0.9%
Wells Fargo Co New0.9%

Largest buys

Since Q2 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Alibaba~$352.1MAdded · 4.4% → 6.4%+2,038,406 shares
  2. Akamai~$187.0MAdded · 0.3% → 0.8%+3,838,581 shares
  3. Baker Hughes~$146.3MNew · 0.0% → 0.4%+3,995,878 shares
  4. Maxim Integrated Prods Inc~$139.3MNew · 0.0% → 0.4%+2,919,287 shares
  5. China Biologic Prods Hldgs I~$84.4MNew · 0.0% → 0.2%+914,848 shares
  6. Abbott Labs~$80.0MAdded · 1.4% → 1.8%+1,500,140 shares
  7. Dowdupont Inc~$68.2MNew · 0.0% → 0.2%+984,994 shares
  8. Priceline Grp Inc~$62.8MAdded · 0.4% → 0.5%+34,288 shares
  9. Oracle~$62.1MAdded · 2.7% → 2.8%+1,285,099 shares
  10. Yum China Hldgs Inc~$58.2MAdded · 0.2% → 0.4%+1,457,341 shares

Largest sells

Since Q2 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Nxp Semiconductors N V~$225.0MCut · 1.4% → 0.8%−1,989,963 shares
  2. Baker Hughes Inc~$215.1MSold out · 0.6% → 0.0%−3,946,169 shares
  3. New Oriental Ed & Tech Grp I~$203.5MCut · 0.9% → 0.6%−2,306,080 shares
  4. Jd Com Inc~$159.0MCut · 1.1% → 0.6%−4,163,597 shares
  5. General Electric Co~$157.5MCut · 1.7% → 1.0%−6,511,803 shares
  6. Cognizant~$147.7MCut · 0.7% → 0.4%−2,035,778 shares
  7. Perkinelmer Inc~$134.7MCut · 0.4% → 0.0%−1,952,683 shares
  8. Omnicom Group~$110.4MCut · 0.5% → 0.1%−1,491,066 shares
  9. China Biologic Prods Inc~$97.4MSold out · 0.3% → 0.0%−861,623 shares
  10. Netease Inc~$90.8MCut · 0.6% → 0.2%−344,260 shares

Holdings

As of Sep 30, 2017. Changes are in shares against Jun 30, 2017, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
HoldingValue
AlibabaSPONSORED ADS · shares +19% · price +22.6%6.4%$2.23B+$345.3M
OracleCOM · shares +6.8% · price −3.6%2.8%$981.3M−$34.0M
Citigroup IncCOM NEW · shares −3.4% · price +8.8%2.7%$932.7M+$75.1M
AlphabetCAP STK CL A · shares +1.5% · price +4.7%2.3%$803.0M+$35.8M
Abbott LabsCOM · shares +15% · price +9.8%1.8%$623.7M+$48.4M
Johnson & JohnsonCOM · shares +0.8% · price −1.7%1.8%$610.8M−$10.6M
Berkshire Hathaway Inc DelCL B NEW · shares +2.8% · price +8.2%1.7%$583.5M+$43.2M
Willis Towers Watson Pub LtdSHS · shares −3.4% · price +6.0%1.7%$578.5M+$32.9M
Pfizer IncCOM · shares +0.2% · price +6.3%1.6%$554.4M+$32.7M
BaiduSPON ADR REP A · shares −8.3% · price +38.5%1.5%$510.3M+$141.8M
Molson Coors Brewing CoCL B · shares −8.8% · price −5.4%1.3%$450.2M−$25.9M
AppleCOM · shares −8.0% · price +7.0%1.3%$449.8M+$29.5M
CiscoCOM · shares −11% · price +7.4%1.2%$430.5M+$29.8M
Verizon Communications IncCOM · shares −7.0% · price +10.8%1.2%$416.2M+$40.6M
Cigna CorporationCOM · shares −3.8% · price +11.7%1.2%$415.8M+$43.5M
MicrosoftCOM · shares +6.8% · price +8.1%1.1%$399.7M+$27.9M
Jpmorgan Chase & CoCOM · shares +3.6% · price +4.5%1.1%$396.5M+$16.5M
General Electric CoCOM · shares −31% · price −10.5%1.0%$354.9M−$41.5M
L3 Technologies IncCOM · shares −10% · price +12.8%0.99%$345.9M+$39.2M
Us Bancorp DelCOM NEW · shares −8.1% · price +3.2%0.98%$341.5M+$10.6M
Ctrip Com Intl LtdAMERICAN DEP SHS · shares +10% · price −2.1%0.94%$328.7M−$6.3M
Bank New York Mellon CorpCOM · shares +0.5% · price +3.9%0.92%$322.6M+$12.1M
Dell Technologies IncCOM CL V · shares −18% · price +26.3%0.92%$321.5M+$67.0M
Wells Fargo Co NewCOM · shares −1.6% · price −0.5%0.92%$319.9M−$1.5M
Procter And Gamble CoCOM · shares +15% · price +4.4%0.91%$317.3M+$11.6M
Total · 500 positions100%$34.88B+$1.58B
The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q2 2017 to Q3 2017: 453 stocks held throughout, up $1.58B (+5.2%).

  1. Alibaba+$345.3M+23%
  2. Baidu+$141.8M+38%
  3. 58 Com Inc+$87.2M+43%
  4. Citigroup Inc+$75.1M+9%
  5. Dell Technologies Inc+$67.0M+26%
  6. Oracle−$34.0M−4%
  7. Mylan N V−$35.9M−19%
  8. Amerisourcebergen Corp−$37.2M−12%
  9. Sabre Corp−$40.1M−17%
  10. General Electric Co−$41.5M−10%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$200.00B$100.00B$0
Q1 2016Q2 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q2 2026$139.27B+8%SEC ↗
Q1 2026$128.75B−4%SEC ↗
Q4 2025$133.60B+5%SEC ↗
Q3 2025$127.26B+9%SEC ↗
Q2 2025$117.10B+11%SEC ↗
Q1 2025$105.25B−2%SEC ↗
Q4 2024$107.04B−3%SEC ↗
Q3 2024$110.32B+9%SEC ↗
Q2 2024$101.14B+0%SEC ↗
Q1 2024$100.86B+6%SEC ↗
Q4 2023$95.18B+12%SEC ↗
Q3 2023$84.91B−5%SEC ↗
Q2 2023$89.00B+2%SEC ↗
Q1 2023$87.18B+5%SEC ↗
Q4 2022$83.33B+7%SEC ↗
Q3 2022$77.76B−7%SEC ↗
Q2 2022$84.03B−14%SEC ↗
Q1 2022$97.56B+0%SEC ↗
Q4 2021$97.50B+8%SEC ↗
Q3 2021$90.05B−3%SEC ↗
Q2 2021$93.16B+6%SEC ↗
Q1 2021$87.86B+8%SEC ↗
Q4 2020$81.21B+1%SEC ↗
Q3 2020$80.63B+9%SEC ↗
Q2 2020$74.16B+22%SEC ↗
Q1 2020$60.86B−16%SEC ↗
Q4 2019$72.13B+9%SEC ↗
Q3 2019$66.13B−0%SEC ↗
Q2 2019$66.34B+4%SEC ↗
Q1 2019$63.83B+13%SEC ↗
Q4 2018$56.35B−17%SEC ↗
Q3 2018$67.62B+2%SEC ↗
Q2 2018$66.31B+82%SEC ↗
Q1 2018$36.38B+1%SEC ↗
Q4 2017$35.93B+3%SEC ↗
Q3 2017$34.88B+1%SEC ↗
Q2 2017$34.67B−2%SEC ↗
Q1 2017$35.55B+4%SEC ↗
Q4 2016$34.11B+2%SEC ↗
Q3 2016$33.41B+6%SEC ↗
Q2 2016$31.39B−3%SEC ↗
Q1 2016$32.30BSEC ↗

Get the newsletter

The day's AI and market news, in your inbox every weekday.